Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJG-136 in Platinum-Refractory Ovarian Cancer
NCT01200797Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jul 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SJG-136 in ovarian epithelial cancer, primary peritoneal carcinoma (PPC), fallopian tube cancer (PFTC), sponsored by National Cancer Institute. Started Jul 2010; status: terminated.
02
Drugs
SJG-136
03
Conditions
ovarian epithelial cancerprimary peritoneal carcinoma (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT01200797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200797.